In this study, we defined the profile of Mtb‐specific IFNγ+ CD4 T‐cell response in TB patients, analysed its evolution after completion of a standard ATT regimen and evaluated how the host CD4 response associates with clinical TB extent and treatment response. The gene discussed is IFNG; the disease is tuberculosis.